Cidomycin 80mg/2ml Solution for Injection
Last Updated on eMC 09-Jul-2015 View document | SANOFI Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 09-Jul-2015 and displayed until Current
Reasons for adding or updating:
- Change to section 7 - Marketing authorisation holder
- Change to section 10 - Date of revision of the text
Date of revision of text on the SPC: 29-Jun-2015
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Section 7 updated to include Sanofi as a trading styleUpdated on 14-May-2015 and displayed until 09-Jul-2015
Reasons for adding or updating:
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Date of revision of text on the SPC: 21-Apr-2015
Legal Category:POM
Black Triangle (CHM): NO
Free-text change information supplied by the pharmaceutical company:
Section 4.8: new textPeripheral neuropathy – Frequency not known
Updated on 30-Sep-2013 and displayed until 14-May-2015
Reasons for adding or updating:
- New SPC for new product
Legal Category:POM
Black Triangle (CHM): NO
SANOFI
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
+44 (0)1483 535 432
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue